P56477
Gene name |
Irf5 |
Protein name |
Interferon regulatory factor 5 |
Names |
IRF-5 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:27056 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
246-430 (IFN association domain) |
Relief mechanism |
PTM |
Assay |
|
Accessory elements
No accessory elements
References
- Lin R et al. (1999) "Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains", Molecular and cellular biology, 19, 2465-74
- Shah M et al. (2015) "In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response", Scientific reports, 5, 13446
- Liu S et al. (2015) "Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation", Science (New York, N.Y.), 347, aaa2630
- Remesh SG et al. (2015) "Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain", The Journal of biological chemistry, 290, 27779-90
- Brass AL et al. (1999) "Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers", The EMBO journal, 18, 977-91
- Barnes BJ et al. (2002) "Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes", Molecular and cellular biology, 22, 5721-40
Autoinhibited structure

Activated structure

1 structures for P56477
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-P56477-F1 | Predicted | AlphaFoldDB |
3 variants for P56477
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs585125464 | 126 | A>G | No | Ensembl | |
rs259714691 | 261 | R>Q | No | Ensembl | |
rs258156314 | 495 | G>S | No | Ensembl |
No associated diseases with P56477
Functions
2 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
7 GO annotations of molecular function
Name | Definition |
---|---|
DNA-binding transcription activator activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that activates or increases transcription of specific gene sets transcribed by RNA polymerase II. |
DNA-binding transcription factor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II. |
identical protein binding | Binding to an identical protein or proteins. |
protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
sequence-specific DNA binding | Binding to DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding. |
sequence-specific double-stranded DNA binding | Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding. |
11 GO annotations of biological process
Name | Definition |
---|---|
cytokine-mediated signaling pathway | The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
defense response to virus | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
positive regulation of apoptotic process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
positive regulation of type I interferon production | Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
regulation of transcription by RNA polymerase II | Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II. |
response to muramyl dipeptide | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muramyl dipeptide stimulus. Muramyl dipeptide is derived from peptidoglycan. |
response to peptidoglycan | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptidoglycan stimulus. Peptidoglycan is a bacterial cell wall macromolecule. |
7 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q58DJ0 | IRF5 | Interferon regulatory factor 5 | Bos taurus (Bovine) | SS |
Q13568 | IRF5 | Interferon regulatory factor 5 | Homo sapiens (Human) | EV |
Q61179 | Irf9 | Interferon regulatory factor 9 | Mus musculus (Mouse) | PR |
Q64287 | Irf4 | Interferon regulatory factor 4 | Mus musculus (Mouse) | EV |
P70671 | Irf3 | Interferon regulatory factor 3 | Mus musculus (Mouse) | SS |
P70434 | Irf7 | Interferon regulatory factor 7 | Mus musculus (Mouse) | SS |
P23611 | Irf8 | Interferon regulatory factor 8 | Mus musculus (Mouse) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MNHSAPGIPP | PPRRVRLKPW | LVAQVNSCQY | PGLQWVNGEK | KLFYIPWRHA | TRHGPSQDGD |
70 | 80 | 90 | 100 | 110 | 120 |
NTIFKAWAKE | TGKYTEGVDE | ADPAKWKANL | RCALNKSRDF | QLFYDGPRDM | PPQPYKIYEV |
130 | 140 | 150 | 160 | 170 | 180 |
CSNGPAPTES | QPTDDYVLGE | EEEEEEEELQ | RMLPGLSITE | PALPGPPNAP | YSLPKEDTKW |
190 | 200 | 210 | 220 | 230 | 240 |
PPALQPPVGL | GPPVPDPNLL | APPSGNPAGF | RQLLPEVLEP | GPLASSQPPT | EPLLPDLLIS |
250 | 260 | 270 | 280 | 290 | 300 |
PHMLPLTDLE | IKFQYRGRAP | RTLTISNPQG | CRLFYSQLEA | TQEQVELFGP | VTLEQVRFPS |
310 | 320 | 330 | 340 | 350 | 360 |
PEDIPSDKQR | FYTNQLLDVL | DRGLILQLQG | QDLYAIRLCQ | CKVFWSGPCA | LAHGSCPNPI |
370 | 380 | 390 | 400 | 410 | 420 |
QREVKTKLFS | LEQFLNELIL | FQKGQTNTPP | PFEIFFCFGE | EWPDVKPREK | KLITVQVVPV |
430 | 440 | 450 | 460 | 470 | 480 |
AARLLLEMFS | GELSWSADSI | RLQISNPDLK | DHMVEQFKEL | HHLWQSQQQL | QPMVQAPPVA |
490 | |||||
GLDASQGPWP | MHPVGMQ |